<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0810">
 <label>162</label>
 <element-citation publication-type="journal" id="rf0690">
  <person-group person-group-type="author">
   <name>
    <surname>Abdallah</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hsu</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Fettner</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Douglass</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Bao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Rowell</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Burmester</surname>
    <given-names>G.R.</given-names>
   </name>
   <name>
    <surname>Kivitz</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetic and pharmacodynamic analysis of subcutaneous tocilizumab in patients with rheumatoid arthritis from 2 randomized, controlled trials: SUMMACTA and BREVACTA: pharmacokinetic and pharmacodynamic analysis of subcutaneous</article-title>
  <source>J. Clin. Pharmacol.</source>
  <volume>57</volume>
  <year>2017</year>
  <fpage>459</fpage>
  <lpage>468</lpage>
  <pub-id pub-id-type="doi">10.1002/jcph.826</pub-id>
  <pub-id pub-id-type="pmid">27599663</pub-id>
 </element-citation>
</ref>
